<DOC>
	<DOCNO>NCT03006237</DOCNO>
	<brief_summary>A Phase 1 Open Label Single Center Safety , Tolerability Pharmacokinetic Study IS-001</brief_summary>
	<brief_title>IS-001 Injection Phase-1 Safety , Tolerance Pharmacokinetics</brief_title>
	<detailed_description>A Phase 1 Open Label Single Center Safety , Tolerability Pharmacokinetic Study IS-001 Injection Patients Undergoing Robotic Hysterectomy Using da Vinci® Si/Xi Surgical System Firefly® Fluorescent Imaging</detailed_description>
	<criteria>1 . Subject age 18 65 . 2 . Subject schedule undergo robotic hysterectomy use da Vinci® Si/Xi surgical system Firefly® fluorescent image . 3 . Subject willing able provide inform consent . 4 . Subject consider capable comply study procedure . 5 . Subject medical history liver kidney disease . 6 . Subject evidence NYHA Class IIIV cardiac disease . 7 . Subject recent ( &lt; 3 month ) clinical hematology ( CBC ) value within acceptable value reference range . 8 . Subject recent ( &lt; 3 month ) clinical serum chemistry ( CMP ) value within acceptable value reference range . 1 . Subject pregnant nursing . 2 . Subject history alcoholism . 3 . Subject history drug abuse . 4 . Subject know active hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) infection . 5 . Subject know human immunodeficiency virus ( HIV ) infection . 6 . Subject diagnose treated cancer last 2 year . 7 . Subject total body weight &lt; 32 kg . 8 . Subject 5 minute supine rest diastolic blood pressure ≥100 mmHg and/or systolic blood pressure ≥160 mmHg . 9 . Subject 5 minute supine rest rest heart rate ≤35 ≥115 bpm . 10 . Subject condition personal circumstance , judgment investigator , might interfere collection complete good quality data represent unacceptable safety liability .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>